These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33822650)

  • 1. The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
    Dürr P; Schlichtig K; Kelz C; Deutsch B; Maas R; Eckart MJ; Wilke J; Wagner H; Wolff K; Preuß C; Brückl V; Meidenbauer N; Staerk C; Mayr A; Fietkau R; Goebell PJ; Kunath F; Beckmann MW; Mackensen A; Neurath MF; Pavel M; Dörje F; Fromm MF
    J Clin Oncol; 2021 Jun; 39(18):1983-1994. PubMed ID: 33822650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy.
    Cuba L; Dürr P; Dörje F; Fromm MF; Schlichtig K
    Clin Pharmacol Ther; 2024 Jul; 116(1):194-203. PubMed ID: 38655859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study.
    Schlichtig K; Dürr P; Dörje F; Fromm MF
    Clin Pharmacol Ther; 2021 Oct; 110(4):1075-1086. PubMed ID: 34118065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial].
    Dürr P; Schlichtig K; Krebs S; Schramm A; Schötz L; Fromm MF; Dörje F
    Z Evid Fortbild Qual Gesundhwes; 2022 Apr; 169():84-93. PubMed ID: 35249863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
    Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
    Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.
    Cuba L; Dürr P; Gessner K; Häcker B; Fietkau R; Siebler J; Pavel M; Neurath MF; Berking C; Wullich B; Brückl V; Beckmann MW; Fromm MF; Dörje F
    JCO Oncol Pract; 2024 Sep; 20(9):1219-1230. PubMed ID: 38848539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial.
    Dürr P; Meier F; Schlichtig K; Schramm A; Schötz L; Fromm MF; Dörje F
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
    Plechschmidt J; Fietkau K; Hepp T; Dietrich P; Fischer S; Krebs S; Neurath MF; Dörje F; Atreya R
    Inflamm Bowel Dis; 2024 Mar; ():. PubMed ID: 38507608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acceptance of an oncologic addendum for the application of the German Standardized Medication Plan in oral anticancer drug therapy].
    Barnert AK; Hofmann P; Liekweg A; Kunze A; Scheid C; Hermes-Moll K; Osburg S; Jaehde U
    Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():29-42. PubMed ID: 36372643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center.
    Cuba L; Schlichtig K; Dürr P; Inwald EC; Fromm MF; Dörje F
    Healthcare (Basel); 2023 Jun; 11(11):. PubMed ID: 37297780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of the feasibility and preliminary efficacy of a texting intervention on medication adherence in adults prescribed oral anti-cancer agents: study protocol.
    Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA
    J Adv Nurs; 2015 Dec; 71(12):2965-76. PubMed ID: 26100719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs.
    Niraula S; Seruga B; Ocana A; Shao T; Goldstein R; Tannock IF; Amir E
    J Clin Oncol; 2012 Aug; 30(24):3012-9. PubMed ID: 22802313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review.
    Lattard C; Baudouin A; Larbre V; Herledan C; Cerutti A; Cerfon MA; Kimbidima R; Caffin AG; Vantard N; Schwiertz V; Ranchon F; Rioufol C
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7905-7924. PubMed ID: 36853384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of a coordinated regional organization to secure the management of patients on oral anticancer drugs: CHIMORAL, a comparative trial].
    Maritaz C; Gault N; Roy C; Tubach F; Burnel S; Lotz JP;
    Bull Cancer; 2019 Sep; 106(9):734-746. PubMed ID: 31130274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a pharmaceutical care programme for patients receiving new molecular-targeted agents in a clinical trial unit.
    Riu G; Gaba L; Victoria I; Molas G; do Pazo F; Gómez B; Creus N; Vidal L
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26786594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).
    Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM
    Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
    Divakaruni A; Saylor E; Duffy AP
    J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of a Text Messaging Intervention to Promote Self-Management for Patients Prescribed Oral Anticancer Agents.
    Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA
    Oncol Nurs Forum; 2015 Nov; 42(6):647-57. PubMed ID: 26488833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.